Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: psoriasis

Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

Jonida Cote, DO, Thomas Harrington, MD, Alicia Meadows, DO, Fan Lin, MD, and Androniki Bili, MD, MPH  |  November 1, 2013

Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:Psoriatic ArthritisSarcoidosisTherapiesTreatmentTumor Necrosis Factor–Alpha Inhibitor

Choosing Wisely’s Treatments, Tests that Pediatric Rheumatologists and Patients Should Question

Kurt Ullman  |  November 1, 2013

From autoantibody panels to assays for Lyme disease, the ACR and ABIM Foundation identify five common tests that are expensive, potentially harmful, and may not improve patient care

Filed under:ConditionsPediatric ConditionsPractice Support Tagged with:AC&RPediatrictests

Rheumatology Drug Updates

Michele D. Kaufman, PharmD, BSc, RPh  |  September 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:acetaminophenadalimumabDrugsFDASafety

Rheumatologists on the Move

Amanda Rillo  |  September 1, 2013

Awards, appointments, and announcements in the world of rheumatology

Filed under:Profiles Tagged with:appointmentsAwardsMovers & Shakers

EULAR 2013: Researchers Expand Targets for PsA, OA Therapy

Thomas R. Collins  |  September 1, 2013

Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:OsteoarthritisPathogenesisPsAPsoriatic Arthritis

Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis

Deborah L. Parks, MD  |  June 1, 2013

Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:JAK inhibitorsRARheumatic DiseaseRheumatoid arthritisTofacitinibTreatment

Salt as a Promoter of Th17 Cells and Autoimmune Disease

Lara C. Pullen, PhD  |  May 21, 2013

New research on Th17 suggests that a high salt diet may be a risk factor for inflammation.

Filed under:Research Rheum Tagged with:Autoimmune diseaseinflammationSaltTh17

Dermatology Case Answer E: May

Alisa Femia, MD and Joseph F. Merola, MD  |  May 14, 2013

E) Impetigo

Filed under:Conditions

Dermatology Case Answer B: May

Alisa Femia, MD and Joseph F. Merola, MD  |  May 14, 2013

B) Keratoderma blennorrhagicum

Filed under:Conditions

Dermatology Case Answer A: May

Alisa Femia, MD and Joseph F. Merola, MD  |  May 14, 2013

A) Pustular ‘Id’ reaction

Filed under:Conditions

  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 55
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences